Reviewed By Don Noren "VITAMIN C AND THE COM- MON COLD," by Linus Pauling (Freeman, 122 pages, $1.95). On Sunday, Dec. 13, I awoke with a scratchy throat and the first stages on head congestion. The next morning, while suffer- ing all the traditional dis- comforts of an ordinary head cold, I consultt?d a copy of Linus Pauling's book, "Vitamin C and the Common Cold." On Monday I took eight 500 mg tablets of ascorbic acid (vitamin C). The following day I repeated the dosage. By Wednesday my cold had totally disappeared. Previously, a nor- mal cold for me had meant at least a week of discomfort. This, of course, is merely one persou's Eaction to the proce- dures recommended by Pauling. He would consider my .dosage extremely moderate. But it Linus PauJing. does, perhaps. provide some in- reaction? The literature is r(<- W I aY dication of the tremendous en- thusiasm and controversy gener- ated by the two-time Nob4 Prize winner's latest book. It may be less of a book than a kind of super-pamphlet. There are sections Ohat appear some. what extraneous in a discussion of colds, but they nevertheless make interesting reading. Why has this particular vol- ume generated so much pubfic plete with previous studies on vitamin C and its potential as a cold cure. It is this literature, coupled with the experiences oi Paulmg and his wife in using a,$- corbic acid as a preventative Reviewer Noren. a University nf California graduate in chemic>t engineering. is president of Noren Produck Redwood City manufac. luring company. -e--F Pauling'j celebrity status ai- tracted a good amount of reader recognition. In addition, he WJS astute enough to develop pre- vious findings more cogently than the original investigators themselves were able to do. He assembled existing literature that supported his viewpoint on vitamin C. and has presented i.f in a manner easily com- prehensible to the layman. At the same time, he points to the case of a physician who sub- mitted a report on ascorbic acid treattnent to 11 professional journals without acceptance. One editor told him it would be harmful to print the ascorbic acid data because medical jour- nals depend heavily on the ad- vertising of cold remedy manu- fact,urers. There is much additional work to be done on the ascorbic acid controversy, but Pauling has correctly declined to take part in i.t because he already has :I viewpoint. If I had to makr LI judgment at this time, I'd guess that in the course of a wide st:l- tistical sample, vitamin C would prove beneficial as a cold fight- er - even if it were not effective in some individual cases.